Insmed (INSM) Change in Acquisitions & Divestments (2010 - 2026)

Insmed's Change in Acquisitions & Divestments history runs 8 years deep, the most recent figure standing at $284.0 million for Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments fell 60.61% year-over-year to $284.0 million in Q1 2026; TTM through Mar 2026 was $1.7 billion, a 15.73% increase from a year earlier, with the FY2025 full-year figure at $2.1 billion, up 106.69% from the prior year.
• Change in Acquisitions & Divestments eased to $284.0 million in Q1 2026 per INSM's latest filing, from $446.0 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $721.0 million in Q1 2025 and bottomed at $10.0 million in Q3 2023.
• The 5-year median for Change in Acquisitions & Divestments is $300.0 million (2023), against an average of $296.2 million.
• Biggest YoY gain for Change in Acquisitions & Divestments was 1100.0% in 2023; the steepest drop was 80.0% in 2023.
• Year by year, Change in Acquisitions & Divestments stood at $25.0 million in 2022, then jumped by 1100.0% to $300.0 million in 2023, then soared by 138.67% to $716.0 million in 2024, then sank by 37.71% to $446.0 million in 2025, then plunged by 36.32% to $284.0 million in 2026.
• Per Business Quant, the three latest INSM Change in Acquisitions & Divestments figures stand at $284.0 million (Q1 2026), $446.0 million (Q4 2025), and $425.0 million (Q3 2025).